Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai Mullerpattan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lung India : Official Organ of Indian Chest Society|September 2, 2025
Phenotyping of asthma population based on inflammatory blood biomarkers and characterisation of phenotypes depending on asthma control, frequency of exacerbations, and associated comorbiditiesBony Francis, Deepak Phalgune, Sanjay Mehendale, et al.
The Journal of the Association of Physicians of India|March 11, 2010
Hermansky-Pudlak syndromeTiyas Sen, Jai Mullerpattan, Dipika Agarwal, et al.
Emerging Infectious Diseases|August 1, 2017
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant TuberculosisAndrey Maryandyshev, Emanuele Pontali, Simon Tiberi, et al.
The Journal of Infection|August 11, 2018
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgerySergey E Borisov, Lia D'Ambrosio, Rosella Centis, et al.
The European Respiratory Journal|May 23, 2017
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studySergey E Borisov, Keertan Dheda, Martin Enwerem, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lung India : Official Organ of Indian Chest Society|September 2, 2025
Phenotyping of asthma population based on inflammatory blood biomarkers and characterisation of phenotypes depending on asthma control, frequency of exacerbations, and associated comorbiditiesBony Francis, Deepak Phalgune, Sanjay Mehendale, et al.
The Journal of the Association of Physicians of India|March 11, 2010
Hermansky-Pudlak syndromeTiyas Sen, Jai Mullerpattan, Dipika Agarwal, et al.
Emerging Infectious Diseases|August 1, 2017
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant TuberculosisAndrey Maryandyshev, Emanuele Pontali, Simon Tiberi, et al.
The Journal of Infection|August 11, 2018
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgerySergey E Borisov, Lia D'Ambrosio, Rosella Centis, et al.
The European Respiratory Journal|May 23, 2017
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studySergey E Borisov, Keertan Dheda, Martin Enwerem, et al.
Pageof 1